| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18473695 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 116 journal articles in the PubMed database | Email to a friend | | |
| Karagiannis E, Pfützner A, Forst T, et al.
The IRIS V Study: Pioglitazone Improves Systemic Chronic Inflammation in Patients with Type 2 Diabetes Under Daily Routine Conditions. [Journal Article]
Diabetes Technol Ther 2008 Jun; 10(3):206-12.
Abstract | Full Citation | Find Related Articles | | Derosa G, Cicero AF, D'Angelo A, et al.
Effects of 1 Year of Treatment with Pioglitazone or Rosiglitazone Added to Glimepiride on Lipoprotein (a) and Homocysteine Concentrations in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome: A Multicenter, Randomized, Double-Blind, Controlled Clinical Trial. [Journal Article]
Clin Ther 2006 May; 28(5):679-88.
Abstract | Full Citation | | Derosa G, Cicero AF, Gaddi A, et al.
Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2004 May; 26(5):744-54.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Derosa G, D'Angelo A, Ragonesi PD, et al.
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome. [Journal Article]
J Clin Pharm Ther 2006 Aug; 31(4):375-83.
Abstract | Full Citation | | Mattoo V, Eckland D, Widel M, et al.
Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2005 May; 27(5):554-67.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Roberts VL, Stewart J, Issa M, et al.
Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study. [Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2005 Oct; 27(10):1535-47.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tan M, Johns D, González Gálvez G, et al.
Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2004 May; 26(5):680-93.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Shand B, Scott R, Connolly S, et al.
Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes. [Journal Article]
Diabetes Obes Metab 2007 Jul; 9(4):540-7.
Abstract | Full Citation | Find Related Articles | | Herz M, Johns D, Reviriego J, et al.
A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2003 Apr; 25(4):1074-95.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
